Citations for

1	CAAG, GSN
	Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type.
	Taira M, Ishiura H, Mitsui J, Takahashi Y, Hayashi T, Shimizu J, Matsukawa T, Saito N, Okada K, Tsuji S, Sawamura H, Amano S, Goto J, Tsuji S.
	Neurogenetics 13(3):237-43. doi: 10.1007/s10048-012-0330-0. Epub 2012 May 24. 2012
2	CAAG, GSN
	The disintegration of a molecule: the role of gelsolin in FAF, familial amyloidosis (Finnish type).
	Robinson RC, Choe S, Burtnick LD.
	Proc Natl Acad Sci U S A 98(5):2117-8. 2001
3	CAAG, GSN
	Elucidating the mechanism of familial amyloidosis- finnish type: NMR studies of human gelsolin domain 2.
	Kazmirski SL, Howard MJ, Isaacson RL, Fersht AR.
	Proc Natl Acad Sci U S A 97(20):10706-11. 2000
4	CAAG, GSN
	In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis.
	Kangas H, et al.
	Hum Mol Genet 5 : 1237-1243. 1996
5	CAAG, GSN
	Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAP IV).
	Steiner RD, et al.
	Hum Genet 95 : 327-330. 1995
6	CAAG, GSN
	Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G654A) of gelsolin in Finland and Japan.
	Paunio T, et al.
	Hum Mutat 6 : 60-65. 1995